title: Benign proliferative breast diseases among female patients at a sub-Saharan Africa tertiary hospital: a cross sectional study.
abstract: BACKGROUND
  Non-cancerous diseases of the breast have assumed increasing importance because of the public awareness of breast cancer. These benign diseases are a recognized important risk factor for later breast cancer which can develop in either breast. The risk estimate of these benign breast diseases has not been well established in sub Saharan Africa. Women with benign proliferative or atypical breast lesions have a two- fold risk of developing breast cancer in western populations. The purpose of this study therefore was to determine the prevalence of proliferative disease ( BPBD) with and without atypia among Ugandan Black women.
  
  
  METHODS
  A cross-sectional descriptive study conducted at Mulago Hospital Breast Clinic between January 2012 and June 2012; 208 women aged 12 years and above with palpable breast lumps were screened. Fine needle aspiration biopsies were taken for cytological examination.
  
  
  RESULTS
  Of the 208 women with benign breast lumps screened, 195 were recruited in the study. The prevalence of BPBD was 18% (35/195). BPBD with atypia was 5.6% (11/195). The mean age and body mass index (BMI) were 28.4 years and 23.26 kg/m2 respectively. The commonest lesions were fibroadenomas for 57%, (111/195), and fibrocystic change were 21% (40/195). Most BPBD with atypia lesions were in the fibrocystic category.
  
  
  CONCLUSIONS
  Benign proliferative breast diseases are common, found mostly among premenopausal women. A significant proportion of BPBD had atypical proliferation. An accurate breast cancer risk estimate study for BPBD is recommended.
authors.affiliation: Department of Surgery, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.
authors.forename: Christopher
authors.initials: C
authors.lastname: Okoth
authors.forename: Moses
authors.initials: M
authors.lastname: Galukande
authors.forename: Josephat
authors.initials: J
authors.lastname: Jombwe
authors.forename: Dan
authors.initials: D
authors.lastname: Wamala
mesh_terms: D000328:Adult; D044383:Black People; D001941:Breast Diseases / Q000175:diagnosis / Q000453:epidemiology* / Q000473:pathology*; D049109:Cell Proliferation; D003430:Cross-Sectional Studies; D005260:Female; D018226:Fibroadenoma / Q000175:diagnosis / Q000453:epidemiology / Q000473:pathology; D005348:Fibrocystic Breast Disease / Q000175:diagnosis / Q000453:epidemiology / Q000473:pathology; D006801:Humans; D012306:Risk; D062606:Tertiary Care Centers; D014454:Uganda / Q000453:epidemiology
references.citation: Cancer. 1993 Apr 15;71(8):2528-31
references.pmid: 8453576
references.citation: Cancer Causes Control. 2010 Jun;21(6):821-8
references.pmid: 20084540
references.citation: N Engl J Med. 2005 Jul 21;353(3):275-85
references.pmid: 16034013
references.citation: Indian J Pathol Microbiol. 2006 Jul;49(3):334-40
references.pmid: 17001879
references.citation: Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2337-43
references.pmid: 18725513
references.citation: N Engl J Med. 2005 Jul 21;353(3):229-37
references.pmid: 16034008
references.citation: Cancer Prev Res (Phila). 2012 Dec;5(12):1375-80
references.pmid: 23087047
references.citation: Pathology. 1998 Aug;30(3):309-13
references.pmid: 9770199
references.citation: Br J Cancer. 2008 Jul 8;99(1):63-7
references.pmid: 18577991
references.citation: J Cell Biochem Suppl. 1993;17G:45-8
references.pmid: 8007708
references.citation: Breast J. 2012 Mar-Apr;18(2):103-10
references.pmid: 22404050
references.citation: Br J Surg. 1985 Jan;72(1):17-8
references.pmid: 3967123
references.citation: Acta Virol. 1975 Nov;19(6):449-56
references.pmid: 1989
references.citation: Sichuan Da Xue Xue Bao Yi Xue Ban. 2004 Nov;35(6):849-53
references.pmid: 15573772
references.citation: Am J Epidemiol. 1984 Aug;120(2):273-80
references.pmid: 6465125
references.citation: J Clin Pathol. 1998 Sep;51(9):695-9
references.pmid: 9930076
references.citation: J Natl Cancer Inst. 2008 Apr 16;100(8):563-71
references.pmid: 18398105
references.citation: N Engl J Med. 1976 Feb 19;294(8):419-22
references.pmid: 1246309
references.citation: Int J Epidemiol. 2000 Aug;29(4):637-44
references.pmid: 10922339
references.citation: Niger Med J. 2011 Oct;52(4):211-6
references.pmid: 22529500
references.citation: Int J Cancer. 1992 Apr 1;50(6):891-4
references.pmid: 1555889
references.citation: J Coll Physicians Surg Pak. 2004 Nov;14(11):654-6
references.pmid: 15533277
references.citation: Cleve Clin J Med. 2002 May;69(5):425-32
references.pmid: 12022387
references.citation: Oncologist. 2006 May;11(5):435-49
references.pmid: 16720843